DBpedia – Linked Data Fragments

Matches in DBpedia 2016-04 for { ?s ?p "Eric J. Topol (born 1954) is an American cardiologist, geneticist, and digital medicine researcher. Before moving to Scripps in 2006, Topol served as chairman of cardiovascular medicine at Cleveland Clinic (1991-2005) and founded the Cleveland Clinic Lerner College of Medicine. Topol was one of the first researchers to question the cardiovascular safety of rofecoxib (Vioxx), culminating in the drug's ultimate withdrawal from the market. Topol's advocacy on the subject led to what the New York Times described as an "unusually public dispute" with the Cleveland Clinic's leadership over ties between the academic institution and the pharmaceutical industry, ultimately leading to Topol's departure from the Clinic after his administrative position as head of the Clinic's academic program was abolished.Topol currently serves as Director of the Scripps Translational Science Institute in La Jolla, California. He also serves as the Chief Academic Officer for Scripps Health, a professor of Genomics at The Scripps Research Institute, and a Senior Consultant at the Division of Cardiovascular Diseases at Scripps Clinic. He is editor-in-chief of Medscape and theheart.org. In 2012, he published a book called The Creative Destruction of Medicine which examined the impact of both the genomic and wireless revolutions on the health care system. In 2013, he appeared on the Colbert Report and examined the host Stephen Colbert using several devices featured in his book. His most recent book The Patient Will See You Now, published in 2015, explores how smartphones, big data, and technology are combining to democratize health care."@en }

• Q5387640 abstract "Eric J. Topol (born 1954) is an American cardiologist, geneticist, and digital medicine researcher. Before moving to Scripps in 2006, Topol served as chairman of cardiovascular medicine at Cleveland Clinic (1991-2005) and founded the Cleveland Clinic Lerner College of Medicine. Topol was one of the first researchers to question the cardiovascular safety of rofecoxib (Vioxx), culminating in the drug's ultimate withdrawal from the market. Topol's advocacy on the subject led to what the New York Times described as an "unusually public dispute" with the Cleveland Clinic's leadership over ties between the academic institution and the pharmaceutical industry, ultimately leading to Topol's departure from the Clinic after his administrative position as head of the Clinic's academic program was abolished.Topol currently serves as Director of the Scripps Translational Science Institute in La Jolla, California. He also serves as the Chief Academic Officer for Scripps Health, a professor of Genomics at The Scripps Research Institute, and a Senior Consultant at the Division of Cardiovascular Diseases at Scripps Clinic. He is editor-in-chief of Medscape and theheart.org. In 2012, he published a book called The Creative Destruction of Medicine which examined the impact of both the genomic and wireless revolutions on the health care system. In 2013, he appeared on the Colbert Report and examined the host Stephen Colbert using several devices featured in his book. His most recent book The Patient Will See You Now, published in 2015, explores how smartphones, big data, and technology are combining to democratize health care.".